Evolocumab, when used with diet, can be used as monotherapy or in combination with other lipid-lowering agents for the prevention of cardiovascular events.
Madelyn Stabinski, PharmD Candidate, Duquesne University, Jonathan Ogurchak, PharmD, CSP
Advertisement
Articles by Madelyn Stabinski, PharmD Candidate, Duquesne University, Jonathan Ogurchak, PharmD, CSP
Advertisement
Latest Updated Articles
Repatha: A Lipid-lowering Monoclonal AntibodyPublished: May 12th 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity
2
From Type 1 to Type 2 and Beyond: Navigating the Landscape of Diabetes
3
COVID-19 Reinfection Heightens Risk of Postacute Sequelae of SARS-CoV-2 in Pediatrics
4
Doxecitine–Doxribtimine Becomes First Approved Treatment for Rare Genetic Disorder
5
